The US Supreme Court cleared the way for a multibillion-dollar racketeering lawsuit that accuses Takeda Pharmaceutical Co.

Amid an outpouring of pharma investment dollars into China, Novartis is the latest multinational drugmaker lining up to ...

Both have plenty to offer investors, but one has a better outlook.

Back in December, 12 mg retatrutide was linked to an efficacy estimand weight loss of 28.7%—and a 75.8% reduction in pain ...

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and ...

Both Lilly and Viking are great buys today and could have bright futures in the weight loss drug market. Though Viking hasn't ...

While Johnson & Johnson retains the top revenue rank across the major pharma companies, Eli Lilly last year established ...

Combining tirzepatide with vitamin B12, a common additive in compounded versions of the drug, yields an impurity that could ...

Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

Roche Holding AG expands Nvidia AI GPUs for drug R&D, tops peers with 3,500+ Blackwell chips, see value vs Eli Lilly and ...